Calmodulin antagonizes amyloid-β peptides-mediated inhibition of brain plasma membrane Ca 2+-ATPase

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 6, 2012, Pages 961-969

  Berrocal, Maria ^a   Sepulveda, M Rosario ^a   Vazquez Hernandez, Maria ^a   Mata, Ana M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Amyloid peptide; Calmodulin; Calpain; Chymotrypsin; PMCA

Indexed keywords

AMYLOID BETA PROTEIN; CALMODULIN; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL TISSUE; ARTICLE; BRAIN; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BINDING SITES; BRAIN; CALCIUM; CALMODULIN; CATTLE; CELL LINE; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COS CELLS; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; PROTEIN BINDING; SIGNAL TRANSDUCTION; SWINE;

EID: 84859085429     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.02.013     Document Type: Article

References (45)

1. Berrocal M., Marcos D., Sepulveda M.R., Perez M., Avila J., Mata A.M. Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease. FASEB J. 2009, 23:1826-1834.
2. Strehler E.E., Zacharias D.A. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol. Rev. 2001, 81:21-50.
3. Brini M., Carafoli E. Calcium pumps in health and disease. Physiol. Rev. 2009, 89:1341-1378.
4. Strehler E.E., Filoteo A.G., Penniston J.T., Caride A.J. Plasma-membrane Ca(2+) pumps: structural diversity as the basis for functional versatility. Biochem. Soc. Trans. 2007, 35:919-922.
5. Sepulveda M.R., Mata A.M. The interaction of ethanol with reconstituted synaptosomal plasma membrane Ca2+ -ATPase. Biochim. Biophys. Acta 2004, 1665:75-80.
6. Carafoli E. Biogenesis: plasma membrane calcium ATPase: 15 years of work on the purified enzyme. FASEB J. 1994, 8:993-1002.
7. Falchetto R., Vorherr T., Brunner J., Carafoli E. The plasma membrane Ca2+ pump contains a site that interacts with its calmodulin-binding domain. J. Biol. Chem. 1991, 266:2930-2936.
8. Falchetto R., Vorherr T., Carafoli E. The calmodulin-binding site of the plasma membrane Ca2+ pump interacts with the transduction domain of the enzyme. Protein Sci. 1992, 1:1613-1621.
9. Salvador J.M., Mata A.M. Purification of the synaptosomal plasma membrane (Ca(2+) + Mg(2+))-ATPase from pig brain. Biochem. J. 1996, 315(Pt 1):183-187.
10. Enyedi A., Verma A.K., Filoteo A.G., Penniston J.T. A highly active 120-kDa truncated mutant of the plasma membrane Ca2+ pump. J. Biol. Chem. 1993, 268:10621-10626.
11. Paszty K., Verma A.K., Padanyi R., Filoteo A.G., Penniston J.T., Enyedi A. Plasma membrane Ca2+ATPase isoform 4b is cleaved and activated by caspase-3 during the early phase of apoptosis. J. Biol. Chem. 2002, 277:6822-6829.
12. Papp B., Sarkadi B., Enyedi A., Caride A.J., Penniston J.T., Gardos G. Functional domains of the in situ red cell membrane calcium pump revealed by proteolysis and monoclonal antibodies. Possible sites for regulation by calpain and acidic lipids. J. Biol. Chem. 1989, 264:4577-4582.
13. Mata A.M., Sepulveda M.R. Calcium pumps in the central nervous system. Brain Res. Brain Res. Rev. 2005, 49:398-405.
14. Berridge M.J. Calcium hypothesis of Alzheimer's disease. Pflugers Arch. 2010, 459:441-449.
15. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 2002, 3:862-872.
16. McLachlan D.R., Wong L., Bergeron C., Baimbridge K.G. Calmodulin and calbindin D28K in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1987, 1:171-179.
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. Sepulveda M.R., Hidalgo-Sanchez M., Mata A.M. A developmental profile of the levels of calcium pumps in chick cerebellum. J. Neurochem. 2005, 95:673-683.
20. Enyedi A., Vorherr T., James P., McCormick D.J., Filoteo A.G., Carafoli E., Penniston J.T. The calmodulin binding domain of the plasma membrane Ca2+ pump interacts both with calmodulin and with another part of the pump. J. Biol. Chem. 1989, 264:12313-12321.
21. Zvaritch E., James P., Vorherr T., Falchetto R., Modyanov N., Carafoli E. Mapping of functional domains in the plasma membrane Ca2+ pump using trypsin proteolysis. Biochemistry 1990, 29:8070-8076.
22. Padanyi R., Paszty K., Penheiter A.R., Filoteo A.G., Penniston J.T., Enyedi A. Intramolecular interactions of the regulatory region with the catalytic core in the plasma membrane calcium pump. J. Biol. Chem. 2003, 278:35798-35804.
23. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 1994, 13:45-53.
24. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 1992, 12:376-389.
25. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 2002, 277:32046-32053.
26. Tycko R. Molecular structure of amyloid fibrils: insights from solid-state NMR. Q. Rev. Biophys. 2006, 39:1-55.
27. Ahmed M., Davis J., Aucoin D., Sato T., Ahuja S., Aimoto S., Elliott J.I., Van Nostrand W.E., Smith S.O. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 2010, 17:561-567.
28. Benaim G., Zurini M., Carafoli E. Different conformational states of the purified Ca2+-ATPase of the erythrocyte plasma membrane revealed by controlled trypsin proteolysis. J. Biol. Chem. 1984, 259:8471-8477.
29. James P., Maeda M., Fischer R., Verma A.K., Krebs J., Penniston J.T., Carafoli E. Identification and primary structure of a calmodulin binding domain of the Ca2+ pump of human erythrocytes. J. Biol. Chem. 1988, 263:2905-2910.
30. Wang J.K., Walaas S.I., Greengard P. Protein phosphorylation in nerve terminals: comparison of calcium/calmodulin-dependent and calcium/diacylglycerol-dependent systems. J. Neurosci. 1988, 8:281-288.
31. James P., Vorherr T., Krebs J., Morelli A., Castello G., McCormick D.J., Penniston J.T., De Flora A., Carafoli E. Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J. Biol. Chem. 1989, 264:8289-8296.
32. Vetter S.W., Leclerc E. Novel aspects of calmodulin target recognition and activation. Eur. J. Biochem. 2003, 270:404-414.
33. Guerini D., Krebs J., Carafoli E. Stimulation of the purified erythrocyte Ca2+-ATPase by tryptic fragments of calmodulin. J. Biol. Chem. 1984, 259:15172-15177.
34. Elshorst B., Hennig M., Forsterling H., Diener A., Maurer M., Schulte P., Schwalbe H., Griesinger C., Krebs J., Schmid H., Vorherr T., Carafoli E. NMR solution structure of a complex of calmodulin with a binding peptide of the Ca2+ pump. Biochemistry 1999, 38:12320-12332.
35. O'Day D.H., Myre M.A. Calmodulin-binding domains in Alzheimer's disease proteins: extending the calcium hypothesis. Biochem. Biophys. Res. Commun. 2004, 320:1051-1054.
36. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3270-3274.
37. Goodman Y., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 1994, 128:1-12.
38. Goodman Y., Steiner M.R., Steiner S.M., Mattson M.P. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 1994, 654:171-176.
39. Osborn K.D., Zaidi A., Urbauer R.J., Michaelis M.L., Johnson C.K. Single-molecule characterization of the dynamics of calmodulin bound to oxidatively modified plasma-membrane Ca2+-ATPase. Biochemistry 2005, 44:11074-11081.
40. Lushington G.H., Zaidi A., Michaelis M.L. Theoretically predicted structures of plasma membrane Ca(2+)-ATPase and their susceptibilities to oxidation. J. Mol. Graph. Model. 2005, 24:175-185.
41. Zaidi A., Barron L., Sharov V.S., Schoneich C., Michaelis E.K., Michaelis M.L. Oxidative inactivation of purified plasma membrane Ca2+-ATPase by hydrogen peroxide and protection by calmodulin. Biochemistry 2003, 42:12001-12010.
42. Michaelis M.L., Bigelow D.J., Schoneich C., Williams T.D., Ramonda L., Yin D., Huhmer A.F., Yao Y., Gao J., Squier T.C. Decreased plasma membrane calcium transport activity in aging brain. Life Sci. 1996, 59:405-412.
43. Gao J., Yin D.H., Yao Y., Sun H., Qin Z., Schoneich C., Williams T.D., Squier T.C. Loss of conformational stability in calmodulin upon methionine oxidation. Biophys. J. 1998, 74:1115-1134.
44. Zaidi A., Michaelis M.L. Effects of reactive oxygen species on brain synaptic plasma membrane Ca(2+)-ATPase. Free Radic. Biol. Med. 1999, 27:810-821.
45. Meyer-Luehmann M., Spires-Jones T.L., Prada C., Garcia-Alloza M., de Calignon A., Rozkalne A., Koenigsknecht-Talboo J., Holtzman D.M., Bacskai B.J., Hyman B.T. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 451:720-724.